- Screening
- Baseline
- In the process of the treatment
- At the end of the treatment
- Follow-up 1
- Follow-up 2
- Follow-up 3
- Management system of participants
- Speciman management system
- Data management system
- ADR/ADE management system
- Madicine management system
- Instruments management system
- SOPs
- Research team
- Design, Methods
|
survial time>1 month | |
|
KPS score between 60-100 or not | |
|
hemoglobin>8 g/dL or not | |
|
platelet count>70*10^9/L or not | |
|
white blood cell counts>4*10^9/L or not |
|
major medical illnesses or psychiatric impairments which will prevent completion of the protocol therapy | |
|
received previous brain irradiation | |
|
could not be regularly followed | |
|
with leptomeningeal involvement |
- Management of the progress
- General information
- Physical examination
- Blood Routine Tests
- Urine and Stool Routine Tests
- Blood Electrolytes Tests
- Coagulation Function Tests
- Serum Liver Function Tests
- HBV Markers Test
- Renel Function Test
- Heat Function Examination
- Blood Cell Morphology
- Image Examinations
- Nervous System Examination
- Lung Function Examination
- Blood Gas Analysis
- Physical Ability Examination
- Health Relative Quality of Life
|
Karnofsky performance status | |
|
Status of primary lesion | |
|
Status of primary lesion | |
|
Brain metastases(n) | |
|
GPA score | |
|
GTV volume | |
|
Maximum tumor diameter(cm) | |
|
Dose of the GTV | |
|
Dose of the CTV | |
|
pathological type | |
|
MMSE score（before radiotherapy） |
- Management for Progress
- Physical examination
- Blood Routine Tests
- Urine and Stool Routine Tests
- Serum Electrolytes Tests
- Liver Function Tests
- HBV Markers Test
- Renel Function Test
- Heat Function Examination
- Image Examinations
- Blood Cell Morphology
- Nervous System Examination
- Lung Function Examination
- Blood Gas Analysis
- Physical Sbility Examination
- Health Relative Quality of Life
|
therapeutic evaluation（1 month later） | |
|
MMSE score（1 month later） | |
|
therapeutic evaluation（3 month later） | |
|
MMSE score（3 month later） | |
|
therapeutic evaluation（6 month later） | |
|
MMSE score（6 month later） | |
|
therapeutic evaluation(1 year later ) | |
|
MMSE score（1 year later） |
|
local control | |
|
Died or not | |
|
survival time |
|
Nausea and vomiting | |
|
weakness | |
|
headache | |
|
hematologic toxicities | |
|
Skin symptoms | |
|
Fever |